NRX Pharmaceuticals, Inc.
NRXP- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001719406
No open-market purchases or sales by NRX Pharmaceuticals, Inc. insiders were filed in the last 90 days; 47 institutions reported holding it in 13F filings for Q2 2026, worth $47.6M in total; no superinvestor holds it.
Q4 2021 vs. Q3 2021
How the institutions holding NRX Pharmaceuticals, Inc. changed between Q3 2021 and Q4 2021.
All holders in Q4 2021All holders in Q3 2021
| Measure | Q3 2021 | Of which not filed for Q4 2021 | Q4 2021 | Change |
|---|---|---|---|---|
| Holders | 23 | 1 | 38 | +16 |
| Shares | 1.75M | 43.5K | 2.59M | +885.0K (+51.8%) |
| Value | $16.2M | $403.0K | $12.4M | −$3.44M (−21.7%) |
1 institution that held it in Q3 2021 haven't filed for Q4 2021 yet. Not filing isn't selling, so the changes leave them out.
New holders (20)
Institutions that held NRX Pharmaceuticals, Inc. at the end of Q4 2021 but not at the end of Q3 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| BlackRock Inc. | 515,448 | $2.46M | 0.00% |
| Virtu Financial LLC | 61,583 | $294.0K | 0.03% |
| Northern Trust Corp | 36,276 | $173.0K | 0.00% |
| Squarepoint Ops LLC | 29,496 | $141.0K | 0.00% |
| Schonfeld Strategic Advisors LLC | 28,100 | $135.0K | 0.00% |
| Alpine Global Management, LLC | 25,326 | $121.0K | 0.02% |
| Engineers Gate Manager LP | 25,210 | $121.0K | 0.01% |
| Goldman Sachs Group Inc | 19,619 | $94.0K | 0.00% |
| Millennium Management LLC | 13,257 | $63.0K | 0.00% |
| Wealthcare Advisory Partners LLC | 13,000 | $62.0K | 0.00% |
| Charles Schwab Investment Management Inc | 12,000 | $58.0K | 0.00% |
| Cubist Systematic Strategies, LLC | 11,773 | $56.0K | 0.00% |
| UBS Group AG | 11,742 | $56.0K | 0.00% |
| Raymond James Financial Services Advisors, Inc. | 11,567 | $55.0K | 0.00% |
| Simplex Trading, LLC | 11,565 | $55.0K | 0.00% |
| State Street Corp | 10,300 | $49.0K | 0.00% |
| Davenport & Co LLC | 10,000 | $48.0K | 0.00% |
| Marshall Wace, LLP | 2,499 | $12.0K | 0.00% |
| Psagot Value Holdings Ltd. / (Israel) | 2,000 | $10.0K | 0.00% |
| Daiwa Securities Group Inc. | 172 | $1.00K | 0.00% |
Sold out (4)
Institutions that held NRX Pharmaceuticals, Inc. at the end of Q3 2021 and filed for Q4 2021 without it.
| Institution | Shares, Q3 2021 | Value, Q3 2021 |
|---|---|---|
| Cambridge Investment Research Advisors, Inc. | 153,523 | $1.42M |
| Citadel Advisors LLC | 135,087 | $1.25M |
| Murchinson Ltd. | 17,900 | $166.0K |
| Jacobi Capital Management LLC | 1,000 | $9.00K |
Not filed for Q4 2021 yet (1)
Institutions that held NRX Pharmaceuticals, Inc. at the end of Q3 2021 and haven't filed a 13F for Q4 2021. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q3 2021 | Value, Q3 2021 |
|---|---|---|
| HighPoint Advisor Group LLC | 43,501 | $403.0K |